Replies to post #39214 on MultiCell Technologies Inc (MCET)

[1gumbi]

Criminal trial. Trial of his peers.

[mrroundtree]

Please don't let your personal vendetta against MCET cloud your "facts".

MCET portfolio of lead drug candidates is in various stages of discovery optimization, and preclinical and clinical development:

MCT-125, a Phase 2 therapeutic candidate for the treatment of PMSF which has demonstrated efficacy in a 138 patient Phase IIa clinical trial.
MCT-465, a preclinical synthetic dsRNA therapeutic candidate and potent immune enhancer for the treatment of solid tumor cancers such as those expressing TLR-3.
MCT-475, a discovery stage antibody therapeutic candidate used in combination with dsRNA for the treatment of solid tumor cancers.
MCT-485, a discovery stage dsRNA therapeutic candidate with tumor cytolytic properties for the treatment of certain cancers.